Evidence map›Paper›PMID 41010902›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Anti-Bacterial, Anti-Viral, and Anti-Inflammatory Properties of Kumazasa Extract: A Potential Strategy to Regulate Smoldering and Inflammation.

Hideki Iwasaki, Shirol Gulam, Tomoji Maeda, Mineo Watanabe, Tokuko Takajo, Soh Katsuyama, Hiroaki Sano, Takanari Tominaga, Akio Ogawa, Ken-Ichi Sako and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hideki IwasakiDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Shirol GulamDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.ORCID 0000-0001-6971-1909
Tomoji MaedaDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Mineo WatanabeDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Tokuko TakajoDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Soh KatsuyamaDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Hiroaki SanoRaffinee International Inc., Tokyo 103-0023, Japan.
Takanari TominagaRaffinee International Inc., Tokyo 103-0023, Japan.
Akio OgawaRaffinee International Inc., Tokyo 103-0023, Japan.
Ken-Ichi SakoDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Toru TakahashiDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.
Takahiro KawaseKyoto Institute of Nutrition and Pathology, Kyoto 610-0231, Japan.
Takamitsu TsukaharaKyoto Institute of Nutrition and Pathology, Kyoto 610-0231, Japan.ORCID 0000-0002-3902-5956
Yoshikazu MatsudaDivision of Clinical Pharmacology, Graduate School of Pharmaceutical Science, Nihon Pharmaceutical University, Ina 362-0806, Japan.

Funding

Raffinee International Inc Joint research agreement 2023
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAnti-Inflammatory AgentsAntiviral AgentsInflammationPlant ExtractsAnimalsAntioxidantsDisease Models, AnimalMaleMiceMicrobial Sensitivity TestsRAW 264.7 CellsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsAntiviral AgentsPlant Extractsanti-bacterial effectanti-inflammatory effectanti-influenza virus effectin vitroin vivoKumazasa extract

Identifiers

PMID41010902
PMCPMC12472022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.